85 related articles for article (PubMed ID: 6801156)
1. [A new method of ovulation induction with HMG-HCG by a E2 rapid radioimmunoassay (author's transl)].
Uemura T; Shirasu K; Matsuyama A; Namiki T; Oomori J; Minaguchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):11-20. PubMed ID: 6801156
[TBL] [Abstract][Full Text] [Related]
2. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
Notation AD; Tagatz GE; Steffes MW
Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
[TBL] [Abstract][Full Text] [Related]
3. [Critical evaluation of clinical and hormonal parameters for the optimal timing of induction of ovulation with gonadotropins (author's transl)].
Hardt W; Schmidt-Gollwitzer M; Boquol E; Stadler C; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1977 Nov; 37(11):925-33. PubMed ID: 924102
[TBL] [Abstract][Full Text] [Related]
4. [A simplified quick semi-quantitative determination of urinary estrogen in non-pregnant female: the application for monitoring of follicular maturation at HMG-HCG therapy].
Kamata S
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):64-72. PubMed ID: 3081668
[TBL] [Abstract][Full Text] [Related]
5. Urinary estradiol-17-beta-glucuronide assay for gonadotropin therapy.
Miyakawa I; Stanczyk FZ; March CM; March AD; Goebelsmann U
Obstet Gynecol; 1981 Aug; 58(2):142-7. PubMed ID: 6789264
[TBL] [Abstract][Full Text] [Related]
6. Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity.
Rapi S; Fuzzi B; Mannelli M; Pratesi S; Criscuoli L; Pellegrini S; Messeri G
Acta Eur Fertil; 1992; 23(2):63-8. PubMed ID: 1338258
[TBL] [Abstract][Full Text] [Related]
7. Ovulation induction with human menopausal gonadotropins.
Diamond MP; Wentz AC
Obstet Gynecol Surv; 1986 Aug; 41(8):480-90. PubMed ID: 3090489
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis-specific serum 17 beta-estradiol (E2) upper limits for treatment with menotropins using a 125I direct E2 assay.
Haning RV; Boehnlein LM; Carlson IH; Kuzma DL; Zweibel WJ
Fertil Steril; 1984 Dec; 42(6):882-9. PubMed ID: 6437878
[TBL] [Abstract][Full Text] [Related]
9. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
Ellenbogen A; David H; Libal Y; Ballas S
Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
[TBL] [Abstract][Full Text] [Related]
10. [Sex hormone binding globulin in stimulated cycles].
Breznik R; Adamcic M; Borko E; Vlaisavljević V
Jugosl Ginekol Opstet; 1984; 24(5-6):84-6. PubMed ID: 6443009
[TBL] [Abstract][Full Text] [Related]
11. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
Olson JL; Rebar RW; Schreiber JR; Vaitukaitis JL
Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
[TBL] [Abstract][Full Text] [Related]
12. [The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
Kooguchi J; Uemura T; Shiojima Y; Iwasaki H
Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):777-85. PubMed ID: 6787830
[TBL] [Abstract][Full Text] [Related]
13. Experience with combined individualized method of hMG/hCG therapy.
Samberg I; Tal J; Zilberman A; Oettinger M; Sharf M
Int J Fertil; 1983; 28(2):85-90. PubMed ID: 6136481
[TBL] [Abstract][Full Text] [Related]
14. [Monitoring of follicles by ultrasonography during induction with HMG-HCG treatment--especially on the prevention of side effects].
Ishimaru T; Okamoto S; Kajimura H; Masuzaki H; Huang HJ; Fuchi T; Yamashita T; Imamura S; Imamichi S; Hata T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):721-9. PubMed ID: 3923140
[TBL] [Abstract][Full Text] [Related]
15. Periovulatory serum prolactin and progesteron secretion in gonadotropin stimulated cycles.
Meden-Vrtovec H; Kocijancic A
Acta Eur Fertil; 1988; 19(4):213-6. PubMed ID: 3147564
[TBL] [Abstract][Full Text] [Related]
16. A new protocol for individualized hMG therapy by estrogen priming and cervical mucus monitoring.
Igarashi M; Yazaki C; Yamada K; Taniguchi Y
Int J Fertil; 1983; 28(2):78-84. PubMed ID: 6136480
[TBL] [Abstract][Full Text] [Related]
17. [Steroid profiles in patients with amenorrhea during induction of ovulation with HMG].
Hidaka T; Hirato K; Shimizu A; Yanaihara T; Nakayama T
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):663-9. PubMed ID: 3108422
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer].
Hara S
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577
[TBL] [Abstract][Full Text] [Related]
19. Ovulation induction by human menopausal gonadotropin with ultrasonic monitoring of the ovarian follicles.
Tulandi T; Hamilton EF; Arronet GH; Coleman PW; McInnes RA
Int J Fertil; 1987; 32(4):312-5. PubMed ID: 2887531
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
Muechler EK; Kohler D; Huang KE
Int J Fertil; 1981; 26(4):273-8. PubMed ID: 6120908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
